Stock Information
Myriad Genetics Inc (MYGN)
Ticker Symbol: MYGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $442.77 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -3.9529
Revenue (TTM): $8.82 M
Dividend Yield: N/A%
ROE: -79.81%
Latest News
-
Myriad Genetics: SOTP Suggests The Company Is Undervalued
Tue, Mar 31, 2026 5:29 PM
Key Financials
Financial data not available